Laurence Buisseret

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 14

Top Topics

Lymph Node Metastasis

Metastatic Breast Cancer

Top Venues

NPJ breast cancer

Journal of clinical medicine

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaoxiao Wang, Laetitia Collet, Mattia Rediti, Véronique Debien, Alex De Caluwé, David Venet, Emanuela Romano, Françoise Rothé, Christos Sotiriou, Laurence Buisseret
Predictive Biomarkers for Response to Immunotherapy in Triple Negative Breast Cancer: Promises and Challenges. Journal of clinical medicine 12 (3) (2023)
Andrea Joaquin Garcia, Mattia Rediti, David Venet, Samira Majjaj, Roswitha Kammler, Elisabetta Munzone, Lorenzo Gianni, Beat Thürlimann, István Láng, Marco Colleoni, Sherene Loi, Giuseppe Viale, Meredith M Regan, Laurence Buisseret, Françoise Rothé, Christos Sotiriou
Differential benefit of metronomic chemotherapy among triple negative breast cancer subtypes treated in the IBCSG Trial 22-00. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Véronique Debien, Alex De Caluwé, Xiaoxiao Wang, Martine J Piccart, Vincent K Tuohy, Emanuela Romano, Laurence Buisseret
Immunotherapy in breast cancer: an overview of current strategies and perspectives. NPJ breast cancer 9 (1) (2023)
Alex De Caluwé, Emanuela Romano, Philip Poortmans, Andrea Gombos, Elisa Agostinetto, Guilherme Nader Marta, Zoe Denis, Stylianos Drisis, Christophe Vandekerkhove, Antoine Desmet, Catherine Philippson, Ligia Craciun, Isabelle Veys, Denis Larsimont, Marianne Paesmans, Dirk Van Gestel, Roberto Salgado, Christos Sotiriou, Martine Piccart-Gebhart, Michail Ignatiadis, Laurence Buisseret
First-in-human study of SBRT and adenosine pathway blockade to potentiate the benefit of immunochemotherapy in early-stage luminal B breast cancer: results of the safety run-in phase of the Neo-CheckRay trial. Journal for immunotherapy of cancer 11 (12) (2023)
Véronique Debien, Alex De Caluwé, Xiaoxiao Wang, Martine J Piccart, Vincent K Tuohy, Emanuela Romano, Laurence Buisseret
Immunotherapy in breast cancer: an overview of current strategies and perspectives. NPJ breast cancer 9 (1) (2023)
Xiaoxiao Wang, Laetitia Collet, Mattia Rediti, Véronique Debien, Alex De Caluwé, David Venet, Emanuela Romano, Françoise Rothé, Christos Sotiriou, Laurence Buisseret
Predictive Biomarkers for Response to Immunotherapy in Triple Negative Breast Cancer: Promises and Challenges. Journal of clinical medicine 12 (3) (2023)
Véronique Debien, Alex De Caluwé, Xiaoxiao Wang, Martine J Piccart, Vincent K Tuohy, Emanuela Romano, Laurence Buisseret
Immunotherapy in breast cancer: an overview of current strategies and perspectives. NPJ breast cancer 9 (1) (2023)
Laurence Buisseret, Delphine Loirat, Philippe Aftimos, Christian Maurer, Kevin Punie, Véronique Debien, Paulus Kristanto, Daniel Eiger, Anthony Goncalves, François Ghiringhelli, Donatienne Taylor, Florent Clatot, Tom Van den Mooter, Jean-Marc Ferrero, Hervé Bonnefoi, Jean-Luc Canon, Fran Ois P Duhoux, Laura Mansi, Renaud Poncin, Philippe Barthélémy, Nicolas Isambert, Zoë Denis, Xavier Catteau, Roberto Salgado, Elisa Agostinetto, Evandro de Azambuja, Françoise Rothé, Ligia Craciun, David Venet, Emanuela Romano, John Stagg, Marianne Paesmans, Denis Larsimont, Christos Sotiriou, Michail Ignatiadis, Martine J Piccart
Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial. Nature communications 14 (1) (2023)
Laurence Buisseret, Delphine Loirat, Philippe Aftimos, Christian Maurer, Kevin Punie, Véronique Debien, Paulus Kristanto, Daniel Eiger, Anthony Goncalves, François Ghiringhelli, Donatienne Taylor, Florent Clatot, Tom Van den Mooter, Jean-Marc Ferrero, Hervé Bonnefoi, Jean-Luc Canon, Fran Ois P Duhoux, Laura Mansi, Renaud Poncin, Philippe Barthélémy, Nicolas Isambert, Zoë Denis, Xavier Catteau, Roberto Salgado, Elisa Agostinetto, Evandro de Azambuja, Françoise Rothé, Ligia Craciun, David Venet, Emanuela Romano, John Stagg, Marianne Paesmans, Denis Larsimont, Christos Sotiriou, Michail Ignatiadis, Martine J Piccart
Author Correction: Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial. Nature communications 14 (1) (2023)
Xiaoxiao Wang, Laetitia Collet, Mattia Rediti, Véronique Debien, Alex De Caluwé, David Venet, Emanuela Romano, Françoise Rothé, Christos Sotiriou, Laurence Buisseret
Predictive Biomarkers for Response to Immunotherapy in Triple Negative Breast Cancer: Promises and Challenges. Journal of clinical medicine 12 (3) (2023)
Daniel Eiger, Marcio Wagner, Noam Falbel Pondé, Melanie Schmitt Nogueira, Laurence Buisseret, Evandro de Azambuja
The impact of cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) on the incidence of alopecia in patients with metastatic breast cancer (BC). Acta oncologica (Stockholm, Sweden) 59 (6) (2020)
Bertrand Allard, David Allard, Laurence Buisseret, John Stagg
The adenosine pathway in immuno-oncology. Nature reviews. Clinical oncology 17 (10) (2020)
Bertrand Allard, Isabelle Cousineau, David Allard, Laurence Buisseret, Sandra Pommey, Pavel Chrobak, John Stagg
Adenosine A2a receptor promotes lymphangiogenesis and lymph node metastasis. Oncoimmunology 8 (8) (2019)
Laurence Buisseret, Soizic Garaud, Alexandre de Wind, Gert Van den Eynden, Anais Boisson, Cinzia Solinas, Chunyan Gu-Trantien, Céline Naveaux, Jean-Nicolas Lodewyckx, Hugues Duvillier, Ligia Craciun, Isabelle Veys, Denis Larsimont, Martine Piccart-Gebhart, John Stagg, Christos Sotiriou, Karen Willard-Gallo
Tumor-infiltrating lymphocyte composition, organization and PD-1/ PD-L1 expression are linked in breast cancer. Oncoimmunology 6 (1) (2016)